Sponsor or institution
Clinical trials and research at Biohaven Pharmaceuticals, Inc.
As of November 12, 2026, Find a Trial lists 6 clinical trials run by Biohaven Pharmaceuticals, Inc. that are recruiting, at sites in 5 countries (most in United States (6), United Kingdom (1), Australia (1)). By phase: Phase 1 (3), Phase 2/3 (1), Phase 3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 5Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| BHV-1300 for adults with Graves’ disease | Phase 3 | Tucson, Arizona and 55 other locations | Recruiting | Jun 22, 2026 |
| BHV-1400 for IgA nephropathy | Phase 1 | Farmington, Connecticut and 14 other locations | Recruiting | Jul 8, 2025 |
| Testing BHV-1300 for treating Graves' Disease | Phase 1 | South Gate, California and 17 other locations | Recruiting | May 20, 2025 |
| Evaluating BHV-8000 for treating early Parkinson's disease in adults | Phase 2/3 | Birmingham, Alabama and 24 other locations | Recruiting | May 16, 2025 |
| Testing BHV-1530 in patients with advanced solid tumors | Phase 1 | Newport Beach, California and 16 other locations | Recruiting | Mar 13, 2025 |
| Testing BHV-1510 for advanced solid tumors | Phase 1/2 | Duarte, California and 16 other locations | Recruiting | Apr 25, 2024 |
All recruiting trials (6)
-
BHV-1300 for adults with Graves’ disease
This study tests BHV-1300 versus placebo in adults whose Graves’ disease makes them hyperthyroid.
-
BHV-1400 for IgA nephropathy
This study will try BHV-1400 in adults with biopsy-confirmed IgA nephropathy to see if the drug is safe and tolerable.
-
Testing BHV-1300 for treating Graves' Disease
This study is testing a new treatment called BHV-1300 to see if it can help people with Graves' Disease manage their symptoms and improve their condition.
-
Evaluating BHV-8000 for treating early Parkinson's disease in adults
This study is testing a new treatment called BHV-8000 to see if it can help adults with early Parkinson's disease feel better.
-
Testing BHV-1530 in patients with advanced solid tumors
This study is testing a new treatment called BHV-1530 to see if it can help adults with advanced solid tumors that haven't improved with standard therapies.
-
Testing BHV-1510 for advanced solid tumors
This study is testing a new treatment called BHV-1510 for people with advanced solid tumors that have already been treated, to see how safe it is and if it works better alone or with another drug.
Quick answers
How many clinical trials run by Biohaven Pharmaceuticals, Inc. are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (6 trials), United Kingdom (1 trial), Australia (1 trial), Canada (1 trial), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 2/3: 1, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.